The research laboratory LabTAU is affiliated to INSERM, the University of Lyon and the Center Leon Bérard. The research at LabTAU aims at using ultrasound for therapy. The expertise of scientists at LabTAU covers acoustics, biomedical engineering, clinical and industrial transfer. In that context, the LabTAU is certified ISO9001 since 2008. Long term collaborations with companies resulted in the clinical evaluation and / or commercialisation of ultrasonic devices for treating prostate cancer (with EDAP TMS), glaucoma (with EyeTechCare) or brain diseases (with Carter) for examples. LabTAU performs a research at the interface between engineering sciences and medicine, and thus benefits from the support of 2 laboratories of excellence, an elite French funding program: Excellence Laboratory Cancer Development and Targeted Therapies (LabEx DEVweCAN) and Excellence Laboratory of Acoustics (LabEx CeLya), with the aim of promoting Lyon to a global hub in the field of oncology and acoustics, respectively, and to attract new talents. In 2017, LabTAU became the 7th Center of Excellence of the FUS Foundation.